JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butler, T. C.
Right arrow Articles by Waddell, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butler, T. C.
Right arrow Articles by Waddell, W. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 110, Issue 2, 241-243, 1954
Copyright © 1954 by American Society for Pharmacology and Experimental Therapeutics


THE ROLE OF THE LIVER IN THE DEMETHYLATION OF N-METHYL DERIVATIVES OF HYDANTOIN AND OF 2,4-OXAZOLIDINEDIONE

Thomas C. Butler 1 and William J. Waddell 1

1 Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Partial hepatectomy in the rat results in a large decrease in the rate of demethylation of l-Mesantoin and of trimethadione.

It is concluded that the liver is the principal, if not the only, site of the demethylation of these drugs.

The suggestion is made that the liver is probably the principal site of demethylation not only of N-methyl derivatives of barbituric acid, hydantoin, and 2,4-oxazolidinedione but also of analogous compounds of other chemical types.

Submitted on October 5, 1953







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1954 by the American Society for Pharmacology and Experimental Therapeutics.